ReadCoor Revenue and Competitors
Estimated Revenue & Valuation
- ReadCoor's estimated annual revenue is currently $387.5k per year.
- ReadCoor's estimated revenue per employee is $77,500
- ReadCoor's total funding is $52.5M.
Employee Data
- ReadCoor has 5 Employees.
- ReadCoor grew their employee count by 25% last year.
ReadCoor's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Mechanical Engineer | Reveal Email/Phone |
2 | Senior Scientist | Reveal Email/Phone |
3 | Senior Director, Business Development | Reveal Email/Phone |
ReadCoor Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is ReadCoor?
ReadCoor is leading the next generation of omics by delivering the first panomic spatial sequencing platform to the global audience of researchers, clinicians, pharma and diagnostics companies, and ultimately patients. It is accomplishing this with Fluorescent in situ Sequencing (FISSEQ), a fundamental new technology, which simultaneously integrates high throughput sequencing, and three-dimensional morphometric analysis. This uniquely powerful platform is expected to revolutionize the next phase in understanding the panomic landscape and may introduce vast new opportunities for important and meaningful clinical insight. Visit www.readcoor.com to learn more.
keywords:N/A
$52.5M
Total Funding
5
Number of Employees
$387.5k
Revenue (est)
25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
ReadCoor News
... Horizon Discovery Ltd., READCOOR, INC., Advanced Cell Diagnostics, Inc., EIKEN CHEMICAL CO, among other domestic and global players.
10x Genomics, S2 Genomics, Inc., NanoString Technologies, Inc., Seven Bridges Genomics, CARTANA AB, READCOOR, INC, Advanced Cell Diagnostics...
Courtesy of ReadCoor ReadCoor, a spatial genomic startup working to advance clinical research and drug discovery, announced Tuesday it raised $27 million in Series B financing, bringing its total money raised to $50 million. The Cambridge-based company said in a statement that it plans to use ...
ReadCoor, Inc., a Cambridge, Mass.-based company focusing on omics and pathology with its 3-dimensional (3D) multi-omic spatial sequencing platform, raised $27m in Series B financing. Backers included new investor Pavilion Capital and existing investors Decheng Capital and Hansjörg Wyss, among ...
ReadCoor, Inc., a company reinventing omics and pathology with its 3-dimensional (3D) multi-omic spatial sequencing platform, today announced a $27 million Series B financing to accelerate the commercialization of its proprietary FISSEQ technology for use in research, drug discovery, and diagnos ...
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.6M | 5 | -17% | N/A |
#2 | $0.1M | 5 | 0% | $4.5M |
#3 | $0.8M | 5 | -17% | N/A |
#4 | $0.4M | 5 | -17% | N/A |
#5 | $0.8M | 5 | 0% | N/A |